Jacklyn Halpin
Nurse Practitioner · Greensboro, NCNPI 1124792841
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 41.6% of the total. Reporting peaked in 2022 at $1,302 and has fallen 92.1% since, to $103 in 2025.
Across 119 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$989
- Galderma Laboratories, L.p.$329
- Xeris Pharmaceuticals, Inc.$90
- Alkermes, Inc.$88
- Novo Nordisk$86
- Amarin Pharma, Inc.$79
- plus $714 from 22 others
What the payments were for
- Food & beverage$2,375100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 43 | $989 |
| Galderma Laboratories, L.p. | 13 | $329 |
| Xeris Pharmaceuticals, Inc. | 6 | $90 |
| Alkermes, Inc. | 4 | $88 |
| Novo Nordisk | 6 | $86 |
| Amarin Pharma, Inc. | 5 | $79 |
| Neurocrine Biosciences, Inc. | 4 | $70 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $61 |
| Biohaven Pharmaceuticals, Inc. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 4 | $56 |
| Lilly USA, LLC | 3 | $52 |
| Neurelis, Inc. | 2 | $42 |
| AstraZeneca | 2 | $38 |
| Novartis | 2 | $36 |
| Bayer | 2 | $33 |
| Ironwood Pharmaceuticals, Inc | 2 | $32 |
| Eisai Inc. | 2 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $27 |
| Amgen | 2 | $27 |
| Antares Pharma, Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| GRT US Holding, Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Irhythm Technologies, Inc. | 1 | $15 |
| GSK | 1 | $15 |
| Merz North America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$233
How this compares
$2,375 in reported general payments places this provider in the 85th percentile of 4,393 nurse practitioner providers in North Carolina.
Other nurse practitioner in Greensboro
- Amber SeilerGreensboro$55K
- Dawn DrazekGreensboro$18K
- Mary PrevostGreensboro$12K
- Sandrivette JohnsonRaleigh$573K
- Ayeshia WrightMocksville$145K
- Jeanann VawterGastonia$97K
- Terra KampJacksonville$72K
- Mary DilorenzoCharlotte$71K
- Olivia OgburnWinston Salem$70K
- Bridget ArchambaultDurham$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.